StockData

HealthEquity vs Nutex Health

HQY and NUTX side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How HQY and NUTX compare

HealthEquity is the larger company, worth 7.0 times as much as Nutex Health ($8.4B against $1.2B).

On earnings, Nutex Health is cheaper: it trades at 6.9× trailing earnings, against 36.8× for HealthEquity.

HealthEquity grew revenue faster over the last twelve months (7.3% versus 6.9% for Nutex Health).

Nutex Health keeps more of each dollar of sales as profit, with a net margin of 21.2% compared with 17.4% at HealthEquity.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricHQYNUTX
Size and price
Market cap$8.4B$1.2B
Share price$101.84$174.51
Change, 1 year0.07%62.9%
Change, 5 years77.5%−72.9%
Beta (5Y)0.391.35
Employees2,814944
StockData Score
Total score1515
Valuation score34 (better)
Growth score3 (better)2
Performance score44
Health score55
Dividend score00
Valuation
P/E36.8×6.9× (better)
P/S6.2×1.4× (better)
P/B4.2×3.0× (better)
EV/EBITDA17.9×3.0× (better)
P/FCF17.3×4.4× (better)
FCF yield5.8%22.9% (better)
Fair value$110.02$623.09
Margin of safety7.4%72.0% (better)
Growth
Revenue growth (TTM)7.3% (better)6.9%
Revenue growth, 5Y average12.4%26.1% (better)
Net income growth (TTM)62.2%219% (better)
EPS growth (TTM)67.9%160% (better)
EPS growth, 5Y average83.0% (better)−17.2%
Profitability
Gross margin71.2% (better)51.3%
Operating margin25.8%43.0% (better)
Net margin17.4%21.2% (better)
FCF margin35.8% (better)32.4%
Return on equity11.4%57.2% (better)
Return on invested capital9.8%142% (better)
Financial health
Debt / equity0.470.10 (better)
Net debt / EBITDA1.33 (better)−0.43
Interest coverage6.7×18.4× (better)
Current ratio2.995.00 (better)
Altman Z-score4.90 (better)4.02
Piotroski F-score9 (better)7
Dividends and buybacks
Buyback yield4.8%–
Shareholder yield4.8% (better)0.00%
Ownership
Held by institutions109%42.9%
Held by insiders1.4%–
Insider net buying, 12 months−$4.1M$2.2K (better)
Short interest, % of float6.7%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.